Literature DB >> 19453632

Different neural systems mediate morphine reward and its spontaneous withdrawal aversion.

Hector Vargas-Perez1, Ryan Ting-A-Kee, Derek van der Kooy.   

Abstract

The opponent-process theory posits that the aversive state of acute opiate withdrawal is a consequence of, and depends on, the previous rewarding state evoked by acute morphine reward. Although the brainstem tegmental pedunculopontine nucleus (TPP) is crucial for the rewarding component of morphine, the source of the later aversive component is not known. It is possible that (i) the second aversive process takes place within the TPP itself or (ii) morphine reward in the TPP activates an unconditioned opponent motivational process in another region of the brain. The effects of reversible inactivation of the TPP on the motivational properties of acute morphine and its spontaneous withdrawal effects in non-drug-dependent rats were examined using a place-conditioning paradigm. Reversible inactivation of the TPP with lidocaine or bupivacaine immediately before the morphine injection blocked the rewarding properties of morphine in non-dependent rats. Blocking the rewarding effects of morphine also blocked the opponent aversive effects of acute morphine withdrawal. In contrast, reversible inactivation of the TPP during the acute morphine withdrawal did not block this opponent aversive process. Our results confirm that the TPP is a critical neural substrate underlying the acute rewarding effects of morphine in non-dependent rats. Furthermore, the opponent aversive process of acute morphine withdrawal is induced by the acute rewarding effects of morphine. However, the TPP does not directly mediate the spontaneous withdrawal aversion (the opponent process), suggesting that a different system, triggered by the changes in the TPP after the primary drug response, produces the aversion itself.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19453632     DOI: 10.1111/j.1460-9568.2009.06749.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  11 in total

1.  Mapping of reinforcing and analgesic effects of the mu opioid agonist endomorphin-1 in the ventral midbrain of the rat.

Authors:  Thomas C Jhou; Sheng-Ping Xu; Mary R Lee; Courtney L Gallen; Satoshi Ikemoto
Journal:  Psychopharmacology (Berl)       Date:  2012-06-06       Impact factor: 4.530

2.  Increased dopamine receptor activity in the nucleus accumbens shell ameliorates anxiety during drug withdrawal.

Authors:  Anna K Radke; Jonathan C Gewirtz
Journal:  Neuropsychopharmacology       Date:  2012-06-13       Impact factor: 7.853

3.  Verifying of participation of nitric oxide in morphine place conditioning in the rat medial septum using nicotinamide adenine dinucleotide phosphate-diaphorase (NADPH-d).

Authors:  Manizheh Karami; Mohsen Karimian Azimi; Mohammad Reza Zarrindast; Zeinab Khalaji
Journal:  Iran Biomed J       Date:  2010-10

4.  Reversal effect of intra-central amygdala microinjection of L-arginine on place aversion induced by naloxone in morphine conditioned rats.

Authors:  Sara Karimi; Manizheh Karami; Hedayat Sahraei; Mahnaz Rahimpour
Journal:  Iran Biomed J       Date:  2011

5.  Depression of home cage wheel running is an objective measure of spontaneous morphine withdrawal in rats with and without persistent pain.

Authors:  Ram Kandasamy; Andrea T Lee; Michael M Morgan
Journal:  Pharmacol Biochem Behav       Date:  2017-03-31       Impact factor: 3.533

6.  An anatomical basis for opponent process mechanisms of opiate withdrawal.

Authors:  Anna K Radke; Patrick E Rothwell; Jonathan C Gewirtz
Journal:  J Neurosci       Date:  2011-05-18       Impact factor: 6.167

7.  BDNF signaling in the VTA links the drug-dependent state to drug withdrawal aversions.

Authors:  Hector Vargas-Perez; Amine Bahi; Mary Rose Bufalino; Ryan Ting-A-Kee; Geith Maal-Bared; Jenny Lam; Ahmed Fahmy; Laura Clarke; Jennifer K Blanchard; Brett R Larsen; Scott Steffensen; Jean-Luc Dreyer; Derek van der Kooy
Journal:  J Neurosci       Date:  2014-06-04       Impact factor: 6.167

8.  Dopaminergic signaling mediates the motivational response underlying the opponent process to chronic but not acute nicotine.

Authors:  Taryn E Grieder; Laurie H Sellings; Hector Vargas-Perez; Ryan Ting-A-Kee; Eric C Siu; Rachel F Tyndale; Derek van der Kooy
Journal:  Neuropsychopharmacology       Date:  2009-12-23       Impact factor: 7.853

Review 9.  Converging vulnerability factors for compulsive food and drug use.

Authors:  Katherine M Serafine; Laura E O'Dell; Eric P Zorrilla
Journal:  Neuropharmacology       Date:  2021-04-20       Impact factor: 5.273

10.  Nitric oxide in central amygdala potentiates expression of conditioned withdrawal induced by morphine.

Authors:  Manizheh Karami; Mahnaz Rahimpour; Sara Karimi; Hedayat Sahraei
Journal:  Indian J Pharmacol       Date:  2014 Jan-Feb       Impact factor: 1.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.